Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$501M |
| 2 |
UnitedHealth
UNH
|
+$307M |
| 3 |
Global Payments
GPN
|
+$302M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$279M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$433M |
| 2 |
Lam Research
LRCX
|
+$373M |
| 3 |
Pfizer
PFE
|
+$354M |
| 4 |
Verizon
VZ
|
+$341M |
| 5 |
EA
Electronic Arts
EA
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.18% |
| 2 | Healthcare | 10.69% |
| 3 | Financials | 10.58% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Enovis
ENOV
$1.48B
| $3.04M | ﹤0.01% |
57,641
-2,280
| -4% | -$133K |
|
2552
Tenaris
TS
$26.6B
| $3.03M | ﹤0.01% |
95,924
+60,933
| +174% | +$1.97M |
|
|
TBNK
2553
DELISTED
Territorial Bancorp Inc.
TBNK
| $3.03M | ﹤0.01% |
333,027
+2,479
| +0.7% | +$27.5K |
|
2554
Magnachip Semiconductor
MX
$137M
| $3.02M | ﹤0.01% |
363,375
-40,914
| -10% | -$357K |
|
|
MODV
2555
DELISTED
ModivCare
MODV
| $3.02M | ﹤0.01% |
95,744
-10,520
| -10% | -$412K |
|
2556
First Merchants
FRME
$2.72B
| $3.01M | ﹤0.01% |
108,076
-3,325
| -3% | -$99.6K |
|
|
BTX
2557
BlackRock Technology and Private Equity Term Trust
BTX
$1.06B
| $3.01M | ﹤0.01% |
431,761
+31,064
| +8% | +$237K |
|
|
ETV
2558
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.77B
| $3M | ﹤0.01% |
239,783
-20,173
| -8% | -$258K |
|
2559
HCI Group
HCI
$2.32B
| $3M | ﹤0.01% |
55,212
-3,088
| -5% | -$176K |
|
2560
United Natural Foods
UNFI
$2.94B
| $2.99M | ﹤0.01% |
211,527
-26,485
| -11% | -$518K |
|
2561
State Street SPDR S&P Health Care Equipment ETF
XHE
$169M
| $2.99M | ﹤0.01% |
38,273
+3,118
| +9% | +$278K |
|
2562
VanEck Emerging Markets High Yield Bond ETF
HYEM
$527M
| $2.98M | ﹤0.01% |
167,334
+14,823
| +10% | +$267K |
|
2563
John B. Sanfilippo & Son
JBSS
$1.01B
| $2.96M | ﹤0.01% |
29,984
-51,534
| -63% | -$5.42M |
|
2564
Global X Silver Miners ETF NEW
SIL
$4.75B
| $2.95M | ﹤0.01% |
123,583
-161,684
| -57% | -$4.2M |
|
2565
Twist Bioscience
TWST
$7.86B
| $2.95M | ﹤0.01% |
145,608
-2,006
| -1% | -$44.1K |
|
|
JWN
2566
DELISTED
Nordstrom
JWN
| $2.94M | ﹤0.01% |
197,021
-97,078
| -33% | -$1.78M |
|
|
AVDL
2567
DELISTED
Avadel Pharmaceuticals
AVDL
| $2.94M | ﹤0.01% |
285,013
+23,334
| +9% | +$313K |
|
2568
PagerDuty
PD
$932M
| $2.94M | ﹤0.01% |
130,504
+120,572
| +1,214% | +$2.88M |
|
2569
B&G Foods
BGS
$299M
| $2.93M | ﹤0.01% |
295,715
-32,351
| -10% | -$401K |
|
2570
Cohen & Steers REIT and Preferred and Income Fund
RNP
$984M
| $2.92M | ﹤0.01% |
170,217
+19,948
| +13% | +$376K |
|
2571
Southside Bancshares
SBSI
$984M
| $2.92M | ﹤0.01% |
101,773
-3,616
| -3% | -$108K |
|
2572
Braze
BRZE
$3.36B
| $2.92M | ﹤0.01% |
+62,442
| New | +$2.74M |
|
|
DBL
2573
DoubleLine Opportunistic Credit Fund
DBL
$282M
| $2.92M | ﹤0.01% |
200,131
+134,199
| +204% | +$1.93M |
|
2574
Vir Biotechnology
VIR
$1.52B
| $2.91M | ﹤0.01% |
311,055
+34,902
| +13% | +$498K |
|
2575
VanEck Pharmaceutical ETF
PPH
$991M
| $2.9M | ﹤0.01% |
36,275
+23,812
| +191% | +$1.92M |
|
Similar funds
Ameriprise's Q3 2023 Portfolio in Review
As of Q3 2023, Ameriprise held 4,031 positions worth $305B, down 4.5% from $319B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ameriprise's Q3 2023 filing shows 127 new, 1,527 increased, 2,081 reduced and 148 closed positions. Its largest new stake was TKO Group: 772,651 shares worth $64.9M. The largest sale was Johnson & Johnson, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q3 2023 buy was TKO Group: 772,651 shares worth $64.9M.
- Ameriprise added most to AT&T in Q3 2023, an estimated $501M increase.
- Ameriprise's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $433M.
- Ameriprise fully exited NiSource Inc. Series A Corporate Units in Q3 2023, selling an estimated $73.8M.
- Ameriprise's ten largest holdings make up 16% of its $305B portfolio in Q3 2023.
- Ameriprise opened 127 new positions and closed 148 in Q3 2023.
- Ameriprise's portfolio value fell 4.5% quarter-over-quarter to $305B.
Based on Ameriprise's 13F filing for Q3 2023, filed 14 Nov 2023.